Longeveron (LGVN) Gross Profit (2020 - 2026)

Longeveron (LGVN) recorded quarterly Gross Profit of $264000.0 in Q1 2026, up 2.72% quarter-over-quarter from $257000.0 in Q4 2025, and down 4.0% on a YoY basis from $275000.0 in Q1 2025.

Longeveron (LGVN) Gross Profit (2020 - 2026) Analysis & Trends

Longeveron's Gross Profit history runs 7 years deep, the most recent figure standing at $264000.0 for Q1 2026.

  • In Q1 2026, Gross Profit fell 4.0% year-over-year to $264000.0; the TTM figure through Mar 2026 stood at $792000.0 (down 56.74% YoY), while the FY2025 annual figure was $803000.0, down 57.38% from the prior year.
  • Gross Profit was $264000.0 for Q1 2026 at Longeveron, up from $257000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $682000.0 in Q3 2024 to a low of -$55000.0 in Q4 2022.
  • Historically, Gross Profit has averaged $207941.2 across 5 years, with a median of $160000.0 in 2022.
  • The sharpest annual moves came in 2022 and 2024: Gross Profit plunged 179.71% in 2022, then jumped 26600.0% in 2024.
  • A 5-year view of Gross Profit shows it stood at -$55000.0 in 2022, then soared by 96.36% to -$2000.0 in 2023, then surged by 26600.0% to $530000.0 in 2024, then plunged by 51.51% to $257000.0 in 2025, then advanced by 2.72% to $264000.0 in 2026.
  • The last three Gross Profit figures came in at $264000.0 (Q1 2026), $257000.0 (Q4 2025), and $125000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 264,000.00
Mar 31, 2026 264,000.00
Dec 31, 2025 257,000.00
Dec 31, 2025 257,000.00
Sep 30, 2025 125,000.00
Sep 30, 2025 125,000.00
Jun 30, 2025 146,000.00
Jun 30, 2025 146,000.00
Mar 31, 2025 275,000.00
Mar 31, 2025 275,000.00
Dec 31, 2024 530,000.00
Dec 31, 2024 530,000.00
Sep 30, 2024 682,000.00
Sep 30, 2024 682,000.00
Jun 30, 2024 344,000.00
Jun 30, 2024 344,000.00
Mar 31, 2024 329,000.00
Mar 31, 2024 329,000.00
Dec 31, 2023 -2,000.00
Dec 31, 2023 -2,000.00